
Ocular Therapeutix Inc
NASDAQ:OCUL

Intrinsic Value
The intrinsic value of one
OCUL
stock under the Base Case scenario is
3.99
USD.
Compared to the current market price of 6.81 USD,
Ocular Therapeutix Inc
is
Overvalued by 41%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Ocular Therapeutix Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Ocular Therapeutix Inc
Balance Sheet Decomposition
Ocular Therapeutix Inc
Current Assets | 441m |
Cash & Short-Term Investments | 392.1m |
Receivables | 32.4m |
Other Current Assets | 16.5m |
Non-Current Assets | 16.9m |
PP&E | 15.3m |
Other Non-Current Assets | 1.6m |
Free Cash Flow Analysis
Ocular Therapeutix Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Ocular Therapeutix Inc
Revenue
|
63.7m
USD
|
Cost of Revenue
|
-5.6m
USD
|
Gross Profit
|
58.1m
USD
|
Operating Expenses
|
-229.9m
USD
|
Operating Income
|
-171.8m
USD
|
Other Expenses
|
-21.7m
USD
|
Net Income
|
-193.5m
USD
|
OCUL Profitability Score
Profitability Due Diligence
Ocular Therapeutix Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Score
Ocular Therapeutix Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
OCUL Solvency Score
Solvency Due Diligence
Ocular Therapeutix Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Score
Ocular Therapeutix Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OCUL Price Targets Summary
Ocular Therapeutix Inc
According to Wall Street analysts, the average 1-year price target for
OCUL
is 17.85 USD
with a low forecast of 14.14 USD and a high forecast of 23.1 USD.
Dividends
Current shareholder yield for OCUL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
OCUL
stock under the Base Case scenario is
3.99
USD.
Compared to the current market price of 6.81 USD,
Ocular Therapeutix Inc
is
Overvalued by 41%.